/ Published in 2017, Publication

What works for human papillomavirus vaccine introduction in low and middle-income countries?

What works for human papillomavirus vaccine introduction in low and middle-income countries?

Howard N, Gallagher KE, Mounier-Jack S, Burchett HE, Griffiths UK, Kabakama S, LaMontagne DS, Watson-Jones D.

Papillomavirus Res 2017;4:22-5.

PMID:29179865

PMCID:PMC5710981

DOI:10.1016/j.pvr.2017.06.003

Related citation

What you can read next

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials
Risk factors for Herpes simplex virus type 2 and HIV among women at high risk in north-western Tanzania: preparing for an HSV-2 intervention trial. Journal of Acquired Immune Deficiency Syndromes 2007; 46: 631-642.
Readiness of Ugandan Health Services for the Management of Outpatients with Chronic Diseases.